Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

The University of Texas System

ClinicalTrials.gov lists The University of Texas System as lead sponsor of 3,157 trials, counting the companies grouped under it.

US Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 6 Related companies not grouped here Related companies not grouped here 7 Disease areas Disease areas 964 Journals published in Journals published in 1,813 US granted patents US granted patents 1 Financing and grant events Financing and grant events 1,653 Organization relationships Organization relationships 371 Latest dated events Latest dated events 5,350 Companies grouped under this page Companies grouped under this page 6 Related companies not grouped here Related companies not grouped here 7 Disease areas Disease areas 964 Journals published in Journals published in 1,813 US granted patents US granted patents 1 Financing and grant events Financing and grant events 1,653 Organization relationships Organization relationships 371 Latest dated events Latest dated events 5,350

Rows recorded per section (log scale)

1 more section with rows · 15 sections measured, none recorded

This page covers The University of Texas System and 6 companies grouped under it: 3,157 lead-sponsored trials (0 its own, 3,157 in the grouped companies) and 8 legal-entity registrations (2 its own, 6 in the grouped companies).

Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.

Get the The University of Texas System report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (6)

Shown in this order: most lead trials first.

Companies grouped under this page
Company Lead trials Legal entities
The University of Texas MD Anderson Cancer Center 3,040 1
The University of Texas at Dallas 59 1
The University of Texas at Arlington 38 1
The University of Texas Health Science Center at Tyler 10 1
The University of Texas at San Antonio 10 1

Disease areas (964)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Diabetes Mellitus 203
Pain 150
Substance-Related Disorders 127
Obesity 123
Diabetes Mellitus, Type 2 95

Journals published in (1,813)

Shown in this order: most published in first.

Journals published in
Journal Publications
The New England journal of medicine 118
JAMA 86
Obstetrics and gynecology 86
Diabetes care 85
Circulation 84

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
131 8 2025-12-30

Financing and grant events (1,653)

Shown in this order: most recent first.

Financing and grant events
Date Round type Amount (USD) Source
2026-05-04 NIH grant 336,218 Reporter
2026-04-24 NIH grant 311,951 Reporter
2026-02-25 NIH grant 150,000 Reporter
2026-02-18 NIH grant 373,187 Reporter
2026-01-29 NIH grant 78,040 Reporter

Organization relationships (371)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Government of the United States of America Co sponsors trial with 72
University of California System Co sponsors trial with 22
Ohio State University Co sponsors trial with 10
Vanderbilt Health Co sponsors trial with 9
M.D. Anderson Cancer Center Co sponsors trial with 9

Latest dated events (5,350)

Shown in this order: newest first.

Latest dated events
Date Event Source
2030-07-30 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2028-08-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2028-01-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2027-08 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2027-07 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarkers this organization publishes on (3,356)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
ERBB2 297
TP53 294
EGFR 257
CD274 246
PDCD1 235

On Scientist.com

The University of Texas System is linked to 15 research suppliers in the Scientist.com network.

Source: Scientist.com supplier network

Not on this page

Checked, with nothing recorded for this organization: trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.

Work with UT MD Anderson Cancer Center DNA Methylation Analysis Core on Scientist.com

For prices, more details, or to contact UT MD Anderson Cancer Center DNA Methylation Analysis Core, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.